Acute myocardial infarction during late pregnancy is a catastrophic event requiring rapid decision-making. Managing acute STEMI in pregnancy demands urgent revascularization, fetal radiation safety, and cross-disciplinary coordination. Historically, pregnancy-associated myocardial infarction carries an alarming maternal case-fatality rate near 4.5 percent. However, modern cardio-obstetric pathways significantly enhance survival. Recently, clinicians treated a 32-year-old primigravida at 38 weeks of gestation who suffered an anterior STEMI from total left anterior descending artery occlusion. Crucially, the cardiology team executed emergent radial-access percutaneous coronary intervention without maternal sedation. They utilized intravascular ultrasound to guide stent deployment accurately. Furthermore, the patient maintained uninterrupted dual antiplatelet therapy through a scheduled cesarean delivery without severe hemorrhage. Both mother and neonate achieved outstanding outcomes and returned home in stable condition. This remarkable case illustrates how advanced intravascular imaging and multidisciplinary protocols resolve complex obstetric-cardiac emergencies.

Differentiating Thrombus from SCAD in STEMI in Pregnancy

Navigating acute coronary syndromes in third-trimester patients demands accurate anatomical differentiation. In standard adult populations, atherosclerotic plaque disruption causes most myocardial infarctions. Conversely, spontaneous coronary artery dissection accounts for substantial proportions of pregnancy-related infarctions. In this patient, angiography initially produced diagnostic ambiguity. Standard angiography cannot always differentiate an occlusive intraluminal thrombus from an intramural hematoma or dissecting flap. Consequently, treating physicians face a major clinical dilemma. If an operator misdiagnoses spontaneous dissection as atherosclerotic thrombosis, aggressive balloon dilation can cause fatal coronary rupture. In contrast, failing to revascularize a genuine thrombotic occlusion leads to extensive myocardial necrosis. In this case, intravascular imaging resolved the diagnostic uncertainty rapidly. Intravascular ultrasound confirmed guidewire passage through a true vessel lumen containing an acute thrombus. Thus, interventional cardiologists avoided dissection propagation and proceeded with safe revascularization. Therefore, clinicians should employ advanced intravascular imaging whenever angiographic images remain ambiguous in pregnant patients.

Diagnostic Utility of Intravascular Ultrasound

Intravascular imaging serves as an essential tool during complex percutaneous coronary intervention. Specifically, intravascular ultrasound provides high-resolution cross-sectional visualization of coronary architecture without requiring heavy radiographic contrast. In pregnant women, excessive iodinated contrast poses potential risks to neonatal thyroid function. Therefore, interventional teams should actively minimize overall contrast administration. Intravascular ultrasound directly visualizes the arterial media, external elastic membrane, and luminal diameter. Consequently, operators can precisely measure vessel dimensions, locate safe landing zones, and guide stent selection. In this patient, intravascular ultrasound verified that the angioplasty guidewire remained within the true vascular lumen. Additionally, it accurately detected a dense thrombus burden rather than a false dissection lumen. Operators then deployed overlapping drug-eluting stents with millimeter accuracy, restoring complete TIMI grade-3 coronary perfusion. Subsequent intravascular imaging confirmed optimal stent apposition without residual edge dissections. As a result, intravascular ultrasound eliminated procedural guesswork, minimized maternal contrast exposure, and achieved complete coronary revascularization.

Radiation Mitigation and Fetal Protection Protocols

Performing fluoroscopic coronary intervention in a near-term gravida requires rigorous radiation safety protocols. Ionizing radiation theoretically threatens the developing fetus with teratogenicity, growth restriction, and childhood malignancy. However, clinicians reduce these risks dramatically by adopting strict ALARA principles. In this emergent case, the interventional team restricted cumulative air kerma well below fetal harm thresholds. Regulatory guidelines established 50 to 100 milligrays as the threshold for potential fetal injury. Routine percutaneous coronary interventions deliver less than 1 milligray directly to the gravid uterus when operators apply pelvic lead shielding. Furthermore, operators positioned the image intensifier close to the patient, utilized low frame-rate fluoroscopy, and avoided extreme cranial angulations. Operators also selected right radial artery access, keeping instrumentation far from the gravid pelvis. In addition, the team avoided maternal conscious sedation, which preserved maternal blood pressure and prevented neonatal respiratory depression. Consequently, modern catheterization laboratories can achieve safe coronary revascularization without causing fetal radiation toxicity.

Balancing Antiplatelet Therapy and Hemostasis During Delivery

Managing antiplatelet pharmacotherapy in a gravida undergoing emergent stenting right before delivery represents an intense clinical challenge. Following drug-eluting stent implantation, dual antiplatelet therapy prevents catastrophic acute stent thrombosis. However, administering potent antiplatelet agents like aspirin and P2Y12 inhibitors increases maternal hemorrhage risks during cesarean section. Furthermore, systemic antiplatelet agents preclude neuraxial anesthesia due to the risk of spinal epidural hematoma. In this case, the cardio-obstetric team chose to continue uninterrupted dual antiplatelet therapy through delivery. They prioritized maternal coronary patency above theoretical surgical bleeding concerns. To mitigate operative blood loss, surgeons and anesthesiologists utilized meticulous surgical technique, topical hemostatic agents, and systemic antifibrinolytics such as tranexamic acid. Additionally, the surgical team coordinated closely with the blood bank for rapid transfusion readiness. Consequently, the surgical team delivered a healthy neonate without experiencing uncontrollable maternal hemorrhage. This protocol demonstrates that multidisciplinary teams can manage uninterrupted dual antiplatelet therapy safely when combining aggressive surgical hemostasis and close perioperative monitoring.

Cardio-Obstetric Team Coordination and Peripartum Delivery Planning

Optimal patient recovery in high-risk obstetric cardiology depends entirely on structured multidisciplinary teamwork. A comprehensive Cardio-Obstetrics Team must include interventional cardiologists, maternal-fetal medicine subspecialists, obstetric anesthesiologists, neonatologists, and critical care nurses. Prior to delivery, these specialists developed a unified peripartum action plan that aligned cardiology interventions with obstetric requirements. For example, the team established continuous electronic fetal monitoring throughout the coronary interventional procedure. Furthermore, obstetric surgeons scheduled the delivery in an operating room equipped with advanced cardiac monitoring tools. The team also formulated an emergency escalation pathway for mechanical circulatory support, such as intra-aortic balloon counterpulsation, in case heart failure developed. Following the successful cesarean section, the mother received monitored post-coronary intensive care, while neonatologists managed the newborn in a dedicated nursery. Consequently, both patients achieved stable recovery and left the hospital without ischemic recurrence or surgical complications. Ultimately, this coordinated multidisciplinary model establishes an effective framework for hospital systems managing near-term cardiovascular emergencies.

Frequently Asked Questions

Why is intravascular ultrasound preferred over standard angiography during pregnancy?

Intravascular ultrasound provides essential high-resolution luminal imaging that distinguishes atherosclerotic or thrombotic occlusions from spontaneous coronary artery dissection. Standard angiograms frequently produce diagnostic ambiguity in pregnant women due to hormonal vessel wall remodeling. Additionally, intravascular ultrasound allows operators to measure vessel dimensions precisely and assess stent expansion without requiring excessive radiopaque contrast. Consequently, clinicians reduce maternal contrast load and avoid misdiagnosing dissections as thrombosis.

How does the clinical team protect the fetus from radiation during catheterization?

Interventional teams maintain fetal radiation doses well below the 50 milligray safety threshold through meticulous procedural adjustments. Operators utilize pelvic lead shielding, low frame-rate fluoroscopy, and radial artery access to minimize scattered radiation. Furthermore, operators avoid steep angulations, collimate the x-ray beam tightly, and optimize the image detector height. These collective safety precautions ensure that the developing fetus absorbs less than 1 milligray during primary coronary interventions.

What strategies minimize bleeding when performing cesarean delivery on dual antiplatelet therapy?

Surgical teams mitigate hemorrhage risks by employing rigorous operative hemostasis, selective electrocautery, and topical procoagulant matrices. Additionally, obstetricians administer intravenous tranexamic acid and ensure immediate availability of packed red blood cells and platelets. Anesthesiologists typically select general endotracheal anesthesia rather than spinal epidural blocks to eliminate epidural hematoma risks. Consequently, maternal teams can safely proceed with necessary surgical delivery without discontinuing essential coronary stent antiplatelet medications.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Darko P et al. STEMI at Term Managed With IVUS-Guided Percutaneous Coronary Intervention and Cesarean Delivery. JACC Case Rep. 2026 Oct 13. doi: undefined. PMID: 42867418.
2. De Backer J, Haugaa KH, Hasselberg NE, et al. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. Eur Heart J. 2025;46(43):4462-4568.
3. Tweet MS, Hayes SN, Codsi E, et al. Spontaneous Coronary Artery Dissection Associated With Pregnancy. J Am Coll Cardiol. 2017;70(4):426-435.
4. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165-3241.